Related Content
- Sagent's injectable antibiotics enter market
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- Walgreens launches high-impact push in support of World AIDS Day campaign
- FDA approves Merck's Gardasil for prevention of anal cancer
SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a generic antibiotic, the company said.
The generic drug maker announced the launch of oxacillin for injection. The drug is a semi-synthetic penicillin used to treat infections caused by penicillinase-producing staphylococci bacteria that have demonstrated susceptibility to the drug.
The drug had sales of $29 million during the 12-month period ended in May, according to IMS Health.
Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.
